H-YML^DLQPETT-OH

Ref. 3D-PP47744

Informations sur le produit

• Nom: H-YML^DLQPETT-OH

Description

Peptide H-YML^DLQPETT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YML^DLQPETT-OH include the following: Cytolytic Activity of the Human Papillomavirus Type 16 E711-20 Epitope-Specific Cytotoxic T Lymphocyte Is Enhanced by Heat Shock Protein 110 in HLA-A*0201 Z Ding, R Ou, B Ni, J Tang, Y Xu - Clinical and Vaccine , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cvi.00721-12 HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach Y Yao , W Huang, X Yang , W Sun, X Liu, W Cun , Y Ma - Vaccine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X13002545 Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer S Oerke, H Höhn, I Zehbe, H Pilch - journal of cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20794 A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7 (11-20) cytotoxic T lymphocyte epitope MWJ Schreurs, EWM Kueter, KBJ Scholten - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05003804 A rapid method to identify cytotoxic T-lymphocyte peptide epitopes from HLA-A2 (+) donors MR Castellanos , G Weinstein, RL Hayes - Critical reviews in oncology , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1040842801001123 Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients MJ Pittet , DE Speiser , D Valmori, D Rimoldi - International , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1567576901000480 Differences in the effectiveness of delivery of B-and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region M Street, K Herd, P Londono, T Doan, G Dougan - Archives of , 1999 - Springerhttps://link.springer.com/article/10.1007/s007050050590 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Katja Nilges, Hanni Höhn, Henryk Pilch, Claudia Neukirch K Freitag, PJ Talbot , MJ Maeurer - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=42484c04bb79d75c8ec3ae0ecfa79514359c66da Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A* 0201-restricted T-cell peptides in cervical cancer patients DW Liu, YC Yang, HF Lin, MF Lin, YW Cheng - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02256-06 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full

• Marque: Biosynth